Health, Fitness & Food

Baby boomers are about to be the largest generation in American history to hit the long-term care space. Born between 1946 and 1964, as defined by Pew Research, the oldest baby boomers are turning 80 next year. The group is set to flood a senior care space that is already understaffed, underfunded and facing political

In this article LLY Follow your favorite stocksCREATE FREE ACCOUNT An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City on Dec. 11, 2023. Brendan McDermid | Reuters Eli Lilly on Tuesday released higher doses of its weight loss drug Zepbound in single-dose vials at as much as half

A doctor looks at an AI-generated clinical note. Courtesy of Athenahealth Health-care software vendor Athenahealth on Tuesday said it will offer Abridge’s artificial intelligence scribing tool to its network of more than 160,000 clinicians.  Athenahealth has developed an electronic health record, revenue cycle management tools and patient engagement tools for ambulatory care providers, which include

In this article LLY Follow your favorite stocksCREATE FREE ACCOUNT Eli Lilly on Wednesday said it will invest at least $27 billion to build four new manufacturing sites in the U.S., as demand for its blockbuster weight loss and diabetes injections soars and the company develops new drugs for other conditions. It comes as drugmakers

In this article TDOC Follow your favorite stocksCREATE FREE ACCOUNT Teladoc Health Inc. signage on the floor of the New York Stock Exchange on Dec. 31, 2024. Michael Nagle | Bloomberg | Getty Images Teladoc Health shares fell in extended trading on Wednesday after the company reported a wider loss than analysts expected and issued

FILE PHOTO: The headquarters of the U.S. Food and Drug Administration (FDA) is seen in Silver Spring, Maryland November 4, 2009.  Jason Reed | Reuters A crucial March meeting of vaccine advisors to the Food and Drug Administration has been canceled without explanation, a member of the advisory panel told CNBC on Wednesday.  The meeting

Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Wednesday’s key moments. 1. The broader market rebounded Wednesday, with the S & P 500 and Nasdaq trying to snap their four-day losing streaks. The Dow was on pace for its third straight

Robert F. Kennedy Jr., U.S. President Trump’s nominee to be Secretary of Health and Human Services, testifies before a Senate Finance Committee confirmation hearing on Capitol Hill in Washington, U.S., Jan. 29, 2025.  Nathan Howard | Reuters A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news

In this article HIMS Follow your favorite stocksCREATE FREE ACCOUNT The Hims app arranged on a smartphone in New York, US, on Wednesday, Feb. 12, 2025.  Gabby Jones | Bloomberg | Getty Images Shares of Hims & Hers Health fell 28% on Tuesday, a day after the telehealth company released fourth-quarter results that disappointed on

In this article HIMS Follow your favorite stocksCREATE FREE ACCOUNT The New York Stock Exchange with a Hims & Hers Health banner is pictured in the Manhattan borough of New York City. Carlo Allegri | Reuters Hims & Hers Health shares plunged 18% in extended trading on Monday after investors looked past better-than-expected revenue and

In this article HIMS NVO NOVO.B-DK Follow your favorite stocksCREATE FREE ACCOUNT Boxes of Ozempic and Wegovy made by Novo Nordisk are seen at a pharmacy. Hollie Adams | Reuters The long-running U.S. shortage of Novo Nordisk‘s blockbuster weight loss injection Wegovy and diabetes treatment Ozempic is resolved after more than two years, the U.S.

The U.S. Food and Drug Administration regulates food and health-related products to ensure they’re safe for public health. Today, it’s estimated to oversee 80% of the U.S. food supply. This also places ingredient safety regulations under the FDA’s authority. According to a 1958 law, companies looking to introduce a new food additive into the food

Jackyenjoyphotography | Moment | Getty Images A popular medical monitor is the latest device produced in China to receive scrutiny for its potential cyber risks.  However, it is not the only health device we should be concerned about. Experts say the proliferation of Chinese health-care devices in the U.S. medical system is a cause for

In this article HIMS Follow your favorite stocksCREATE FREE ACCOUNT Hims & Hers Shares of Hims & Hers Health closed down around 26% on Friday after the U.S. Food and Drug Administration announced that the shortage of semaglutide injection products has been resolved. Semaglutide is the active ingredient in Novo Nordisk‘s blockbuster weight loss drug Wegovy and

In this article BLUE Follow your favorite stocksCREATE FREE ACCOUNT Sopa Images | Lightrocket | Getty Images Bluebird Bio will sell itself to private equity firms Carlyle and SK Capital for about $30 million, the company said Friday, marking the end of the Bluebird’s fall from the one of the buzziest biotech firms to one

In this article ME Follow your favorite stocksCREATE FREE ACCOUNT Anne Wojcicki attends the WSJ Magazine Style & Tech Dinner in Atherton, California, on March 15, 2023. Kelly Sullivan | Getty Images Entertainment | Getty Images 23andMe CEO Anne Wojcicki and New Mountain Capital have submitted a proposal to take the embattled genetic testing company

FILE PHOTO: The logo of Down Jones Industrial Average stock market index listed company UnitedHealthcare is shown in Cypress, California April 13, 2016.  Mike Blake | Reuters UnitedHealthcare is in hot water again as the insurance giant grapples with a reported government investigation of its Medicare billing practices, pursues employee buyouts and potential layoffs and

In this article LLY Follow your favorite stocksCREATE FREE ACCOUNT Dan Skovronsky knows what makes a good obesity drug. As chief scientific officer at Eli Lilly, he’s already done it once with the company’s weekly shot, Zepbound. He’s trying to do it again with a more convenient daily pill, then repeat the feat with a

In this article LLY Follow your favorite stocksCREATE FREE ACCOUNT Heart disease. Hearing loss. Addiction. Chronic pain. Alzheimer’s. ALS. These are some of the areas where Eli Lilly, flush with cash from its GLP-1 drugs, wants to make big bets.  These are the ideas that are “hiding in plain sight,” said Lilly Chief Scientific Officer

Steve Christo | Corbis News | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Novo Nordisk‘s blockbuster diabetes drug Ozempic may also help people drink less alcohol.  That’s according to new government-funded research